Niagen Bioscience (NAGE) executive compensation, 2026 proxy

Robert Fried, Chief Executive Officer, was paid $8.4M in 2025, up 592% from $1.2M the year before. The CEO-to-median-employee pay ratio was 67:1, on median employee pay of $124,378.

Filed
April 29, 2026
Annual meeting
June 24, 2026
Pay year
2025
Named executives
3
CEO total pay
$8.4M+592% vs prior year
CEO to median employee
67:1median $124,378
CEO pay in equity
86%$7.2M in awards
Prior say-on-pay support
97%of votes cast
CEO 2025 Total Compensation
$8,381,900Significant increase driven by stock awards
CEO Base Salary
$645,962Effective January 1, 2025
CEO Non-Equity Incentive
$565,378Annual cash bonus earned
CEO Pay Ratio
67:1Relative to median employee

How Fried was paid

$8.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary8%Stock awards62%Option awards23%Non-equity incentive7%

Named executive officers

ExecutiveTotal
Robert FriedChief Executive Officer$8,381,900
Ozan PamirChief Financial Officer$716,475
Carlos LopezSVP, General Counsel$558,014

What changed and why

  • $8.4MChief executive officer total compensation increased to $8,381,900 in 2025 compared to $1,212,131 in 2024.
  • $646KBase salary for the chief executive officer was adjusted to $645,962 for 2025.
  • $5.2MStock awards totaling $5,220,188 were granted to the chief executive officer in 2025.
  • $565KNon-equity incentive plan compensation of $565,378 was awarded to the chief executive officer for 2025.
  • 97%Over 97 percent of votes cast approved named executive officer compensation at the prior meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.